ModelEdge

Tonix Pharmaceuticals Holding Corp
TNXP
Filing Type10-K
Filing Date3/17/2025
Updated3/18/25, 2:42 PM

Filing

10-K
Earnings Release

Exhibits

10-KFY 2024
EX-4.06DESCRIPTION OF REGISTRANT'S SECURITIES
EX-10.56BASE AGREEMENT BETWEEN ADVANCED TECHNOLOGY INTERNATIONAL AND TONIX PHARMACEUTICALS, INC.
EX-10.57PROJECT AGREEMENT NO. 1 BY AND BETWEEN ADVANCED TECHNOLOGY INTERNATIONAL AND TONIX PHARMACEUTICALS, INC.
EX-19.01TONIX PHARMACEUTICALS HOLDING CORP. INSIDER TRADING POLICY
EX-21.01LIST OF SUBSIDIARIES
EX-23.01CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
EX-31.01CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302
EX-31.02CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302
EX-32.01CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 906
EX-97.01TONIX PHARMACEUTICALS HOLDING CORP. COMPENSATION RECOVERY POLICY
GRAPHICGraphic